ATE280161T1 - Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten - Google Patents
Imidazolverbindungen als alpha2-adrenorezeptoren antagonistenInfo
- Publication number
- ATE280161T1 ATE280161T1 AT01942360T AT01942360T ATE280161T1 AT E280161 T1 ATE280161 T1 AT E280161T1 AT 01942360 T AT01942360 T AT 01942360T AT 01942360 T AT01942360 T AT 01942360T AT E280161 T1 ATE280161 T1 AT E280161T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha2
- imidazole compounds
- adrenoreceptor antagonists
- adrenoreceptor
- antagonists
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 229940082496 Adrenoreceptor antagonist Drugs 0.000 title 1
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 title 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20000073A FI20000073A0 (fi) | 2000-01-14 | 2000-01-14 | Uusia imidatsolijohdannaisia |
| PCT/FI2001/000030 WO2001051472A1 (en) | 2000-01-14 | 2001-01-12 | New imidazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE280161T1 true ATE280161T1 (de) | 2004-11-15 |
Family
ID=8557065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01942360T ATE280161T1 (de) | 2000-01-14 | 2001-01-12 | Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1261588B1 (de) |
| JP (1) | JP2003519688A (de) |
| KR (1) | KR20020084091A (de) |
| CN (1) | CN1187336C (de) |
| AR (1) | AR029432A1 (de) |
| AT (1) | ATE280161T1 (de) |
| AU (1) | AU769896B2 (de) |
| BR (1) | BR0107644A (de) |
| CA (1) | CA2397283A1 (de) |
| CZ (1) | CZ20022358A3 (de) |
| DE (1) | DE60106572T2 (de) |
| DK (1) | DK1261588T3 (de) |
| EE (1) | EE200200389A (de) |
| ES (1) | ES2228884T3 (de) |
| FI (1) | FI20000073A0 (de) |
| GC (1) | GC0000218A (de) |
| HK (1) | HK1049999B (de) |
| HU (1) | HUP0301008A3 (de) |
| IL (1) | IL150506A0 (de) |
| MX (1) | MXPA02006872A (de) |
| NO (1) | NO323117B1 (de) |
| NZ (1) | NZ519919A (de) |
| PE (1) | PE20011230A1 (de) |
| PL (1) | PL207281B1 (de) |
| PT (1) | PT1261588E (de) |
| RU (1) | RU2265598C2 (de) |
| SI (1) | SI1261588T1 (de) |
| SK (1) | SK286320B6 (de) |
| WO (1) | WO2001051472A1 (de) |
| ZA (1) | ZA200205301B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20002756A0 (fi) * | 2000-12-15 | 2000-12-15 | Orion Yhtymae Oyj | Uusi hoitomenetelmä |
| TW200930291A (en) | 2002-04-29 | 2009-07-16 | Bayer Cropscience Ag | Pesticidal heterocycles |
| FI20022159A0 (fi) * | 2002-12-05 | 2002-12-05 | Orion Corp | Uusia farmaseuttisia yhdisteitä |
| DE102004035322A1 (de) * | 2004-07-21 | 2006-02-16 | Universität des Saarlandes | Selektive Hemmstoffe humaner Corticoidsynthasen |
| CA2666762C (en) | 2006-10-19 | 2014-12-30 | F. Hoffmann-La Roche Ag | Aminomethyl-4-imidazoles |
| MX2009005047A (es) * | 2006-11-16 | 2009-05-25 | Hoffmann La Roche | 4-imidazoles sustituidos. |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| AR090557A1 (es) * | 2012-04-02 | 2014-11-19 | Orion Corp | DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2225782A (en) * | 1988-12-09 | 1990-06-13 | Farmos Group Limited | Imidazole derivatives useful for treatment of diabetes |
| GB2244431A (en) * | 1990-05-31 | 1991-12-04 | Farmos Oy | Treatment of age related memory impairment and other cognitive disorders |
| GB9113077D0 (en) * | 1991-06-18 | 1991-08-07 | Orion Yhtymae Oy | Use of atipamezole |
| US5541211A (en) * | 1991-06-18 | 1996-07-30 | Orion-Yhtyma Oy | Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission |
| GB9127050D0 (en) * | 1991-12-20 | 1992-02-19 | Orion Yhtymae Oy | Substituted imidazole derivatives and their preparation and use |
| GB9520150D0 (en) * | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| PT1036065E (pt) * | 1997-12-04 | 2004-09-30 | Allergan Inc | Derivados de imidazol substituidos com actividade do tipo agonista nos receptores alfa 2b ou 2b/2c adrenergicos |
| US6503935B1 (en) * | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| TWI283669B (en) * | 1999-06-10 | 2007-07-11 | Allergan Inc | Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
-
2000
- 2000-01-14 FI FI20000073A patent/FI20000073A0/fi unknown
-
2001
- 2001-01-10 GC GCP20011133 patent/GC0000218A/en active
- 2001-01-12 HU HU0301008A patent/HUP0301008A3/hu unknown
- 2001-01-12 PE PE2001000029A patent/PE20011230A1/es not_active Application Discontinuation
- 2001-01-12 CN CNB018037194A patent/CN1187336C/zh not_active Expired - Fee Related
- 2001-01-12 DK DK01942360T patent/DK1261588T3/da active
- 2001-01-12 MX MXPA02006872A patent/MXPA02006872A/es active IP Right Grant
- 2001-01-12 AR ARP010100140A patent/AR029432A1/es unknown
- 2001-01-12 PL PL356884A patent/PL207281B1/pl not_active IP Right Cessation
- 2001-01-12 CA CA002397283A patent/CA2397283A1/en not_active Abandoned
- 2001-01-12 EP EP01942360A patent/EP1261588B1/de not_active Expired - Lifetime
- 2001-01-12 EE EEP200200389A patent/EE200200389A/xx unknown
- 2001-01-12 ES ES01942360T patent/ES2228884T3/es not_active Expired - Lifetime
- 2001-01-12 AT AT01942360T patent/ATE280161T1/de not_active IP Right Cessation
- 2001-01-12 DE DE60106572T patent/DE60106572T2/de not_active Expired - Lifetime
- 2001-01-12 SI SI200130256T patent/SI1261588T1/xx unknown
- 2001-01-12 NZ NZ519919A patent/NZ519919A/en unknown
- 2001-01-12 HK HK03102023.4A patent/HK1049999B/zh not_active IP Right Cessation
- 2001-01-12 SK SK998-2002A patent/SK286320B6/sk not_active IP Right Cessation
- 2001-01-12 CZ CZ20022358A patent/CZ20022358A3/cs unknown
- 2001-01-12 KR KR1020027009037A patent/KR20020084091A/ko not_active Ceased
- 2001-01-12 PT PT01942360T patent/PT1261588E/pt unknown
- 2001-01-12 BR BR0107644-2A patent/BR0107644A/pt not_active Application Discontinuation
- 2001-01-12 IL IL15050601A patent/IL150506A0/xx not_active IP Right Cessation
- 2001-01-12 JP JP2001551854A patent/JP2003519688A/ja active Pending
- 2001-01-12 RU RU2002121777/04A patent/RU2265598C2/ru not_active IP Right Cessation
- 2001-01-12 WO PCT/FI2001/000030 patent/WO2001051472A1/en not_active Ceased
- 2001-01-12 AU AU28532/01A patent/AU769896B2/en not_active Ceased
-
2002
- 2002-07-02 ZA ZA200205301A patent/ZA200205301B/xx unknown
- 2002-07-08 NO NO20023298A patent/NO323117B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030472L (no) | Imidazolderivater | |
| DE60134094D1 (de) | C7-taxanester als antitumormittel | |
| NO20023424L (no) | Kortikotropin-frigjörende faktorantagonister | |
| DE60012031D1 (de) | Piperazin verbindungen als tachykinin-antagonisten | |
| ATE299875T1 (de) | Benzoamid-piperidin verbindungen als substanz p- antagonisten | |
| ATE286036T1 (de) | Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren | |
| ATE384053T1 (de) | Triazolderivate als tachykininrezeptor- antagonisten | |
| DK1358165T3 (da) | Imidazolderivater | |
| ATE360620T1 (de) | Imidazolderivate | |
| ATE339417T1 (de) | Biphenyl - sulfonamide als duale angiotensin - endothelin - rezeptor - antagonisten | |
| ATE291575T1 (de) | N-carbamoyloxyalkyl-substituierte azolium- verbindungen | |
| NO20026196L (no) | Kinazolinditosylatsalt-forbindelser | |
| ATE277933T1 (de) | Thiophenverbindungen zur verwendung als antikrebsmittel | |
| DK1619192T3 (da) | Arylkondeserede azapolycykliske forbindelser | |
| ATE439344T1 (de) | Muscarin-antagonisten | |
| DE60140368D1 (de) | Substitutuierte imidazole als tafia inhibitoren | |
| DE60118569D1 (de) | 4-phenylpyridin-derivate als neurokinin-1-rezeptor-antagonisten | |
| DE60114852D1 (de) | Chinazolin-derivate als alpha-1 adrenerge antagonisten | |
| ATE245653T1 (de) | Imidazolverbindungen als phosphodiesterase vii- hemmer | |
| ATE428420T1 (de) | Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer | |
| DE50206096D1 (de) | Substituierte benzoäbüazepin-2-on-verbindungen als schmerzmittel | |
| ATE286018T1 (de) | Biphenylderivate als neurokinin-1 antagonisten | |
| NO20025659L (no) | Heterocykliske forbindelser | |
| ATE280161T1 (de) | Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten | |
| ATE264301T1 (de) | Muscarin-antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1261588 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |